Patheon 2Q Revenues: $181 million (-5%) 2Q Loss: $22 million (earnings were $3 million in 2Q2006) YTD Revenues: $352.7 million (+1%) YTD Loss: $24 million (loss of $8.5 million YTD2006) Comments: Rx manufacturing services revenues were down $6.3 million, or 4%, due to volume declines for two major products manufactured at Caguas, PR: Zocor, which lost patent protection in June 2006, and Levothyroxine sodium, which experienced loss of market share. These declines were partia...